164 related articles for article (PubMed ID: 22792369)
1. CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.
Ferrer IR; Wagener ME; Song M; Ford ML
PLoS One; 2012; 7(7):e40559. PubMed ID: 22792369
[TBL] [Abstract][Full Text] [Related]
2. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
[TBL] [Abstract][Full Text] [Related]
3. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
4. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
5. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
Wu Z; Wang Y; Gao F; Shen X; Zhai Y; Kupiec-Weglinski JW
J Immunol; 2008 Jul; 181(2):1096-102. PubMed ID: 18606661
[TBL] [Abstract][Full Text] [Related]
6. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of donor-specific transfusion sources: unique failure of bone marrow cells to induce prolonged skin allograft survival with anti-CD154 monoclonal antibody.
Markees TG; Pearson T; Cuthbert A; Pearson AL; Shultz LD; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
Transplantation; 2004 Dec; 78(11):1601-8. PubMed ID: 15591948
[TBL] [Abstract][Full Text] [Related]
8. Alloreactive CD8 T-cell primed/memory responses and accelerated graft rejection in B-cell-deficient sensitized mice.
Ji H; Shen XD; Gao F; Busuttil RW; Zhai Y; Kupiec-Weglinski JW
Transplantation; 2011 May; 91(10):1075-81. PubMed ID: 21427633
[TBL] [Abstract][Full Text] [Related]
9. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
Chen Y; Heeger PS; Valujskikh A
J Immunol; 2004 May; 172(9):5456-66. PubMed ID: 15100287
[TBL] [Abstract][Full Text] [Related]
10. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
[TBL] [Abstract][Full Text] [Related]
11. Defective alloreactive CD8 T cell function and memory response in allograft recipients in the absence of CD4 help.
Zhai Y; Wang Y; Wu Z; Kupiec-Weglinski JW
J Immunol; 2007 Oct; 179(7):4529-34. PubMed ID: 17878349
[TBL] [Abstract][Full Text] [Related]
12. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
Jarvinen LZ; Blazar BR; Adeyi OA; Strom TB; Noelle RJ
Transplantation; 2003 Nov; 76(9):1375-9. PubMed ID: 14627918
[TBL] [Abstract][Full Text] [Related]
13. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
Thornley TB; Brehm MA; Markees TG; Shultz LD; Mordes JP; Welsh RM; Rossini AA; Greiner DL
J Immunol; 2006 Feb; 176(3):1561-70. PubMed ID: 16424185
[TBL] [Abstract][Full Text] [Related]
14. Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade.
Turgeon NA; Iwakoshi NN; Phillips NE; Meyers WC; Welsh RM; Greiner DL; Mordes JP; Rossini AA
J Surg Res; 2000 Sep; 93(1):63-9. PubMed ID: 10945944
[TBL] [Abstract][Full Text] [Related]
15. Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization.
Xu H; Yan J; Huang Y; Chilton PM; Ding C; Schanie CL; Wang L; Ildstad ST
Blood; 2008 Mar; 111(6):3266-75. PubMed ID: 17827394
[TBL] [Abstract][Full Text] [Related]
16. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming.
Burns AM; Chong AS
J Immunol; 2011 Jan; 186(1):214-21. PubMed ID: 21135169
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing IL-7 promotes long-term allograft survival induced by CD40/CD40L costimulatory blockade.
Wang Y; Dai H; Liu Z; Cheng X; Tellides G; Dai Z
Am J Transplant; 2006 Dec; 6(12):2851-60. PubMed ID: 17062001
[TBL] [Abstract][Full Text] [Related]
18. High-frequency alloreactive T cells augment effector function of low-frequency CD8+ T-cell responses under CD28/CD154 blockade.
Floyd TL; Orr SB; Coley SM; Hanna SS; Wagener ME; Kirk AD; Larsen CP; Ford ML
Transplantation; 2010 May; 89(10):1208-17. PubMed ID: 20407401
[TBL] [Abstract][Full Text] [Related]
19. Skin allograft maintenance in a new synchimeric model system of tolerance.
Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
[TBL] [Abstract][Full Text] [Related]
20. An anti-CD154 domain antibody prolongs graft survival and induces Foxp3(+) iTreg in the absence and presence of CTLA-4 Ig.
Pinelli DF; Wagener ME; Liu D; Yamniuk A; Tamura J; Grant S; Larsen CP; Suri A; Nadler SG; Ford ML
Am J Transplant; 2013 Nov; 13(11):3021-30. PubMed ID: 24007441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
